TG Therapeutics
TGTX
#3292
Rank
A$6.61 B
Marketcap
A$41.67
Share price
0.24%
Change (1 day)
-14.03%
Change (1 year)

Earnings for TG Therapeutics (TGTX)

Earnings in 2025 (TTM): A$0.17 Billion

According to TG Therapeutics's latest financial reports the company's current earnings are A$0.53 Billion. In 2024 the company made an earning of A$70.21 Million, an increase over its 2023 earnings that were of A$36.23 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for TG Therapeutics from 1996 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) A$0.17 B154.14%
2024 A$70.21 M93.76%
2023 A$36.23 M-113.65%
2022 -A$0.27 Billion-45.06%
2021 -A$0.49 Billion25.42%
2020 -A$0.39 Billion62.93%
2019 -A$0.24 Billion-3.34%
2018 -A$0.25 Billion46.05%
2017 -A$0.17 Billion48.38%
2016 -A$0.12 Billion29.09%
2015 -A$87.47 Million12.99%
2014 -A$77.41 Million180.92%
2013 -A$27.56 Million
2009 -A$2.51 Million-59.85%
2008 -A$6.23 Million
2006 -A$14.12 Million-48.34%
2005 -A$27.32 Million215.12%
2004 -A$8.67 Million29.1%
2003 -A$6.72 Million159.59%
2002 -A$2.59 Million
2000 -A$4.45 Million12.38%
1999 -A$3.96 Million7.69%
1998 -A$3.67 Million-49.02%
1997 -A$7.2 Million82.14%
1996 -A$3.96 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Alkermes
ALKS
A$0.57 B 252.69%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Dr. Reddy's Laboratories
RDY
A$1.23 B 659.41%๐Ÿ‡ฎ๐Ÿ‡ณ India